Development and Evaluation of Transdermal Patches of Celecoxib

References

1. ↵
   Arthritis Research Campaign. Arthritis: The Big Picture. http://www.arc.org.uk/about_arth/bigpic.htm (accessed May 17, 2004).
2. ↵
   1. Kean W. F.,
   2. Buchanan W. W.

   The use of NSAIDs in rhumatic disorders: a global perspective. Inflammopharmacology 2005, 13 (4), 343–370.

   OpenUrlCrossRefPubMed
3. ↵
   1. Hawkey C. J.

   Non-steroidal anti-inflammatory drugs and peptic ulcers. Br. Med. J. 1990, 300 (6720), 278–284.

   OpenUrlFREE Full Text
4. ↵
   1. Griffin M. R.,
   2. Scheiman J. M.

   Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am. J. Med. 2001, 110 (1A), 33S–37S.

   OpenUrlCrossRefPubMed
5. ↵
   1. Monkhouse D. C.,
   2. Huq A. S.

   Transdermal drug delivery—problems and promises. Drug Dev. Ind. Pharm. 1988, 14 (2), 183–209.

   OpenUrl
6. ↵
   Micromedex (R) Healthcare Series Vol. 125..
7. ↵
   1. Reddy M. N.,
   2. Rehana T.,
   3. Ramakrishna S.,
   4. Chowdary K. P. R.,
   5. Diwan P. V.

   β-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies. AAPS Pharm. Sci. 2004, 6 (1), Article 7, 1–9.

   OpenUrlCrossRef
8. ↵
   1. Paulson S. K.,
   2. Vaughn M. B.,
   3. Jessen S. M.,
   4. Lawal Y.,
   5. Gresk C. J.,
   6. Yan B.,
   7. Maziasz T. J.,
   8. Cook C. S.,
   9. Karim A.

   Pharmacokinetics of celecoxib after oral administration in dogs and humans. J. Pharmacol. Exp. Ther. 2001, 297 (2), 638–645.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Winter C. A.

   Anti-Inflammatory Testing Methods: Comparative Evaluation of Indomethacin and Other Agents. In Garattini and Dukes International Symposium on Nonsteroidal Anti-Inflammatory Drugs; Excerpta Medica: Amsterdam, 1965, Vol. 82, pp 190–202.

   OpenUrl
10. 1. Carstensen J. T.

    Drug Stability: Principle and Practices, Carstensen J. T., Ed.; Marcel Dekker Inc.: New York, 1990; Vol. 43.
11. ↵
    1. Arora P.,
    2. Mukherjee B.

    Design, development, physicichemical, and in-vitro and in-vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 2002, 91 (9), 2076–2089.

    OpenUrlPubMed
12. ↵
    1. Panchagnula R.,
    2. Kandavilli S.,
    3. Nair V.

    Polymers in transdermal drug delivery systems. Pharm. Tech. 2002, 26 (5), 62–80.

    OpenUrl
13. ↵
    1. Megrab N. A.,
    2. Williams A. C.,
    3. Barry B. W.

    Estradiol permeation through human skin and silastic membrane—effects of propylene glycol and supersaturation. J. Controlled Release 1995, 36 (3), 277–294.

    OpenUrl
14. ↵
    1. Rao R. P.,
    2. Diwan P. V.

    Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm. 1998, 24 (4), 327–36.

    OpenUrlPubMed
15. ↵
    1. Robinson J. R.,
    2. Lee V. H. L.

    Controlled Drug Delivery: Fundamentals and Applications, 2nd ed.; Marcel Dekker Inc.: New York, 1987; Vol. 29, pp 140–159 and 524–549.

    OpenUrl
16. ↵
    1. Chien Y. W.

    Development of transdermal drug delivery systems. Drug Dev. Ind. Pharm. 1987, 13 (4), 589–651.

    OpenUrl
17. ↵
    1. Ranade V. V.

    Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 1991, 31 (5), 401–418.

    OpenUrlPubMed
18. ↵
    1. Fan L. T.,
    2. Sing S. K.

    Controlled Release: A Quantitative Treatment. Springer Verlag: New York, 1989; pp 13–56 and 85–29.
19. ↵
    1. Andersson T. L.,
    2. Stehle B.,
    3. Davidsson B.,
    4. Hoglund P.

    Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Clinmara. Maturitas 2000, 34 (1), 57–64.

    OpenUrlPubMed
20. ↵
    1. Bond D. A.,
    2. Smith P. A.

    Modeling the transport of low-molecular-weight penetrants within polymer matrix composites. Applied Mechanics Reviews 2006, 59 (5), 249–268.

    OpenUrl
21. ↵
    1. Jiang S. J.,
    2. Zhou X. J.

    Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. Biol. Pharm. Bull. 2003, 26 (1), 66–68.

    OpenUrlPubMed